Is CorMedix Inc. (CRMD) a Buy, Sell, or Hold?
NASDAQ : CRMD
CorMedix Inc. — Analyst Ratings
$7.87 USD
-$0.18 (-2.24%)
- Volume
- 625.29K
- Average Volume
- 1.3M
- Market Capitalization
- $617.42M
- P/E Ratio
- 3.31
- Dividend Yield
- 0.00%
- Price Target
- $13.50
- Year High
- $14.96
- Year Low
- $6.13
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.98
Analyst Consensus Summary
Consensus Rating
Buy
8 Analysts
Rating Score
4/5
Recommendation Strength
Upside/Downside
-41.7%
vs Current Price
Price Target
$13.50
Average TargetPrice Target Range
Lowest Target
$13.00
-39.5% DOWNSIDE
Average Target
$13.50
Median Estimate
Highest Target
$14.00
-43.8% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 8
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 8 | 0 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| RBC Capital | Leonid Timashev | $14 | $7.82 | 2026-04-28 07:41 AM | 79.0% |
| Leerink Partners | Roanna Ruiz | $13 | $6.46 | 2026-03-06 03:13 PM | 101.2% |
| RBC Capital | Gregory Renza | $22 | $12.16 | 2025-10-21 07:08 AM | 80.9% |
| H.C. Wainwright | Brandon Folkes | $17 | $10.33 | 2025-08-08 06:03 AM | 64.6% |
| RBC Capital | Gregory Renza | $9 | $3.9 | 2024-03-13 02:21 AM | 130.8% |